Cover Image
Market Research Report
Product code 
997991

Orphan Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Disease Type, and By Region - Size, Share, & Forecast from 2021-2027

Published: | AnalystView Market Insights | 267 Pages | Delivery time: 2-3 business days

Price

Back to Top
Orphan Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Disease Type, and By Region - Size, Share, & Forecast from 2021-2027
Published: March 1, 2021
AnalystView Market Insights
Content info: 267 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

REPORT HIGHLIGHT

The global Orphan Drugs market was valued at USD 160.0 billion in 2020, growing with 10.9% CAGR during the forecast period, 2021-2027.

Orphan drugs are termed as a molecule which is used for treating rare diseases. According to European Organization, these drugs are produced for the treating, diagnosis, & prevention of rare diseases. Thus, the patients suffering from these disorders seek potent treatment.

Market Dynamics

The Orphan Drug market is estimated to witness a substantial growth rate in the next few years. The increasing target population with rare diseases and rising R&D investment is boosting the growth of orphan drugs. To reduce the growing prevalence of rare diseases, the developed and developing countries have formulated regulations that promote drug development and enabling these drugs so that they can available easily to patients. The average approval time of a non-orphan drug is around 13 months. European Union (EU) has implemented similar initiatives for the development of drugs. Some of them include Specialty Solidarity Fund in Belgium, Italy- AIFA 5.0% Fund.

Furthermore, the increasing R&D investment by key players for drug development is also boosting the market growth. In addition, the growing awareness levels about rare diseases the number of clinical biopharmaceutical companies have a strong pipeline for clinical trials of orphan drugs. Further, the increasing number of research & development of disease therapeutics is expected to positively impact market growth. The growing target patient population with rare is expected to bolster the market growth. For example, According to the European Organization of rare diseases in 2020, over 300.0 million people are suffering from one or more rare diseases across the world. However, the high cost linked with orphan drugs may restrain the growth of the market.

The orphan drugs market is segregated into drug type and disease type segments. Based on drug type, the biologics segment held the largest revenue share in 2019. By disease type, the oncology segment is projected to offer potential growth opportunities for the market over the forecast period.

Regional Insights

North America held the largest revenue share of over 45.0% in 2019. The presence of an established healthcare network, key players and a growing patient population is boosting regional growth. In addition, supportive government policies, & funding are boosting regional growth. For example, according to NIH, in 2017, there were around 7,000 rare diseases found in the U.S. with approximately 25 to 30.0 million Americans sufferings from rare diseases. Europe is projected to exceed at a significant rate from 2021 to 2027. Asia Pacific is expected to expand at the highest CAGR over the forecast period.

Competitive Landscape

The orphan drugs market is moderately competitive with the major dominating the global market. The top players include F.Hoffman La Roche AG, Johnson & Johnson, and Novartis AG. TE Connectivity Ltd and Honeywell International, Inc. Key players in the market engage in strategic initiatives, collaboration, and new product developments to remain competitive in the market. For example, in May 2020, AstraZeneca has received FDA approval product that is used for treating acromegaly a rare disease.

Key features of the study:

This proposed research study on Orphan Drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Orphan Drugs market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Orphan Drugs market

Impact of COVID-19 on Orphan Drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Orphan Drugs market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Orphan Drugs market, we have also included competitive landscape and key innovator analysis for the Orphan Drugs market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Orphan Drugs market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Orphan Drugs market on global as well as regional level.

The global Orphan Drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORPHAN DRUGS MARKET KEY PLAYERS

Bayer AG

F. Hoffman LA Roche AG

Novo Nordisk A/S

Amgen Inc.

Novartis AG

Johnson & Johnson

Celegne Corporation

Takeda Pharmaceutical Company Limited

AstraZeneca

GlaxoSmithKline PLC

Bristol Myers Squibb Company

Alexion Pharmaceutical Inc.

DAIICHI SANKYO Company Ltd.

GLOBAL ORPHAN DRUGS MARKET, BY DRUG TYPE

Biologics

Non-biologics

GLOBAL ORPHAN DRUGS MARKET, BY DISEASE TYPE

Oncology

Neurology

Hematology

Cardiovascular

Endocrinology

Immunotherapy

Others

GLOBAL ORPHAN DRUGS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Orphan Drugs Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Drug Type
    • 2.1.2. Market Snippet by Disease Type
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. Orphan Drugs Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Orphan Drugs Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Orphan Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Orphan Drugs Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Orphan Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2020 & 2027 (%)
  • 7.2. Biologics
  • 7.3. Non-biologics

8. Orphan Drugs Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2020 & 2027 (%)
  • 8.2. Oncology
  • 8.3. Neurology
  • 8.4. Hematology
  • 8.5. Cardiovascular
  • 8.6. Endocrinology
  • 8.7. Immunotherapy
  • 8.8. Others

9. Orphan Drugs Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease Type, 2016 - 2027, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.3.10. Rest of Europe
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.10.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.10.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.4.10. Rest of APAC
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.10.3. Rest of APAC Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.10.4. Rest of APAC Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.5.9. Rest of LATAM
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.9.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.9.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2016 - 2027 (US$ Million)

10. Key Vendor Analysis

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Bayer AG
    • 10.2.2. F. Hoffman LA Roche AG
    • 10.2.3. Novo Nordisk A/S
    • 10.2.4. Amgen Inc.
    • 10.2.5. Novartis AG
    • 10.2.6. Johnson & Johnson
    • 10.2.7. Celegne Corporation
    • 10.2.8. Takeda Pharmaceutical Company Limited
    • 10.2.9. AstraZeneca
    • 10.2.10. GlaxoSmithKline PLC
    • 10.2.11. Bristol Myers Squibb Company
    • 10.2.12. Alexion Pharmaceutical Inc.
    • 10.2.13. DAIICHI SANKYO Company Ltd.

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Orphan Drugs market: Drug Types Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Types
  • TABLE Global Orphan Drugs market, by Drug Types 2016-2027 (USD Million)
  • TABLE Orphan Drugs market: Disease Type Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Orphan Drugs market, by Disease Type 2016-2027 (USD Million)
  • TABLE Orphan Drugs market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Orphan Drugs market, by Region 2016-2027 (USD Million)
  • TABLE North America Orphan Drugs market, by Country, 2016-2027 (USD Million)
  • TABLE North America Orphan Drugs market, by Drug Types, 2016-2027 (USD Million)
  • TABLE North America Orphan Drugs market, by Disease Type, 2016-2027 (USD Million)
  • TABLE Europe Orphan Drugs market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Orphan Drugs market, by Drug Types, 2016-2027 (USD Million)
  • TABLE Europe Orphan Drugs market, by Disease Type, 2016-2027 (USD Million)
  • TABLE Asia Pacific Orphan Drugs market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Orphan Drugs market, by Drug Types, 2016-2027 (USD Million)
  • TABLE Asia Pacific Orphan Drugs market, by Disease Type, 2016-2027 (USD Million)
  • TABLE Latin America Orphan Drugs market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Orphan Drugs market, by Drug Type, 2016-2027 (USD Million)
  • TABLE Latin America Orphan Drugs market, by Disease Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Orphan Drugs market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Orphan Drugs market, by Drug Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Orphan Drugs market, by Disease Type, 2016-2027 (USD Million)

List of Figures

  • FIGURE Orphan Drugs market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Drug Type segment market share analysis, 2020 & 2027
  • FIGURE Drug Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2020 & 2027
  • FIGURE Disease Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Orphan Drugs market share and leading players, 2019
  • FIGURE Europe Orphan Drugs market share and leading players, 2019
  • FIGURE Asia Pacific Orphan Drugs market share and leading players, 2019
  • FIGURE Latin America Orphan Drugs market share and leading players, 2019
  • FIGURE Middle East and Africa Orphan Drugs market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Orphan Drugs market share analysis by country, 2019
  • FIGURE Germany Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Orphan Drugs market share analysis by country, 2019
  • FIGURE India Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Orphan Drugs market share analysis by country, 2019
  • FIGURE Brazil Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Orphan Drugs market share analysis by country, 2019
  • FIGURE Saudi Arabia Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Orphan Drugs market size, forecast and trend analysis, 2016 to 2027 (USD Million)